Status:
RECRUITING
Inflammatory Biomarkers as Predictors of PONV Following Pediatric Orchiopexy
Lead Sponsor:
Diskapi Yildirim Beyazit Education and Research Hospital
Conditions:
Pediatric Anesthesia
Postoperative Nausea and Vomiting (PONV)
Eligibility:
All Genders
1-8 years
Brief Summary
Orchiopexy is a common surgical procedure for the treatment of cryptorchidism in the pediatric population, with a high incidence of postoperative nausea and vomiting (PONV). Recent evidence suggests ...
Eligibility Criteria
Inclusion
- Patients aged between 1 and 8 years
- Patients with ASA physical status I-II
- Patients scheduled for elective orchiopexy
- Obtained written informed consent from parents/guardians
Exclusion
- Patients younger than 1 year or older than 8 years
- Patients with ASA physical status III or higher
- Presence of acute infection signs
- History of previous nausea or vomiting
Key Trial Info
Start Date :
September 8 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 27 2026
Estimated Enrollment :
170 Patients enrolled
Trial Details
Trial ID
NCT07148063
Start Date
September 8 2025
End Date
March 27 2026
Last Update
September 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ankara Etlik City Hospital
Altındağ, Ankara, Turkey (Türkiye)